Keyphrases
Tumor Necrosis Factor-α
84%
Mesenchymal Stem Cells
71%
Endometrial Stem Cells
49%
Mesenchymal Stromal Cells
44%
Sepsis
37%
Polymorphism
35%
Acute Respiratory Distress Syndrome
32%
Promoter Region
31%
Nitric Oxide Synthase 2
31%
Exosomes
30%
Cell-based
30%
Rheumatoid Arthritis
30%
Tumor Necrosis Factor Genes
29%
Lipopolysaccharide-induced
28%
Genetic Polymorphism
28%
Chilean
25%
Gene Promoter
24%
MicroRNA
23%
Macrophages
23%
Adult Cardiomyocytes
23%
Inflammatory Response
22%
Systemic Lupus Erythematosus
21%
Antimicrobial Peptides
21%
Antimicrobial Activity
21%
Factor Level
18%
Cardiomyocytes
18%
Bioink
18%
Gene Transcription
18%
Menstrual Blood
17%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
17%
Rheumatoid Arthritis Patients
17%
Human Mesenchymal Stem Cells (hMSCs)
16%
Lipopolysaccharide
16%
Attenuation
15%
Anti-tumor Necrosis Factor Therapy
15%
Therapeutic Effect
15%
Cyclooxygenase-2
15%
Promoter Polymorphism
15%
Antiangiogenic Activity
15%
Angiogenesis
15%
Immunosuppressive Potential
15%
Allogeneic
15%
Clinical Trials
15%
Regenerative Medicine
15%
Cell Therapy
14%
Intercommunication
14%
Chorion
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Patients with Heart Failure
14%
Antibiotics
14%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Promoter Region
62%
Tumor Necrosis Factor
56%
Inflammatory Arthritis
43%
Stem Cell
28%
Genetic Polymorphism
28%
Tumor Necrosis Factor Alpha
28%
Antimicrobial Agent
28%
Systemic Lupus Erythematosus
27%
Antimicrobial Peptides
23%
Mediator
20%
Exosome
19%
Antimicrobial Activity
18%
Allele
18%
Angiogenesis
16%
Stem Cell Transplantation
16%
Cytotoxicity
15%
Umbilical Cord
14%
Squamous Cell
14%
Nitric Oxide Synthase 2
14%
Cardiac Muscle Cell
14%
Chorion
14%
Periodontitis
14%
Diabetes Mellitus Type 1
14%
Osteoarthritis
14%
Macrophage
14%
Infliximab
14%
Knee
14%
Immunosuppressive Drug
14%
Lupus Erythematosus
14%
Inflammatory Cell
14%
Hematopoietic Cell
14%
Bone Marrow Derived Mesenchymal Stem Cell
14%
Drug Megadose
11%
Low Drug Dose
11%
Secretion (Process)
11%
Mesenchymal Stem Cell Transplantation
11%
Prostaglandin
9%
Survival Rate
9%
Inflammatory Cytokine
9%
Mouse Model
9%
Biological Functions
9%
Inflammation Response
9%
Colony Forming Unit S
8%
B Cell
8%
Single Nucleotide Polymorphism
7%
Neutrophil Granulocyte
7%
Optimal Drug Dose
7%
Bacterial Clearance
6%
Restriction Fragment Length Polymorphism
6%
Medicine and Dentistry
Mesenchymal Stem Cell
71%
Umbilical Cord
31%
Systemic Lupus Erythematosus
25%
Cell Therapy
20%
Exosome
19%
microRNA
16%
Clinical Trial
16%
Stem Cell
14%
Angiogenesis
14%
Immunosuppressive Drug
14%
Stem Cell Therapy
14%
Thrombocyte Poor Plasma
14%
Chorion
14%
Virus Infection
14%
Mouth Squamous Cell Carcinoma
14%
Knee Osteoarthritis
14%
Heart Disease
14%
Randomized Clinical Trial
14%
Lupus Erythematosus
14%
Cardiac Muscle Cell
14%
Tumor Progression
14%
Dental Pulp
14%
Stromal Cell
14%
Biological Marker
14%
Randomized Controlled Trial
14%
COVID-19
14%
Intravenous Drug Administration
14%
Antimicrobial Agent
14%
Congestive Heart Failure
14%
Hematopoietic Cell
14%
Pulmonary Hypertension
14%
Umbilical Cord-Derived Mesenchymal Stem Cell
12%
Mesenchymal Stem Cell Transplantation
11%
Osteoarthritis
10%
Drug Megadose
10%
Low Drug Dose
10%
Acute Respiratory Distress Syndrome
9%
Ejection Fraction
8%
Dentin
7%
Knee Joint
7%
In Vitro
6%
Cyclooxygenase 2
5%
Inducible Nitric Oxide Synthase
5%
Signal Transduction
5%
Cytokine
5%
Lipopolysaccharide
5%
Adverse Event
5%
Endothelial Cell
5%
Health Care Cost
5%
